TSE:JWEL

Jamieson Wellness (JWEL.TO)

41.93
+0.19 (0.46%)
as of Jul 15, 2026, 8:00:00 pm Market Open.
152 watching
0
Investor Insights
star iconJul 16, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Jamieson Wellness (JWEL-T) has garnered positive reviews from analysts who highlight its strong core business performance and the potential for future unsolicited takeout offers. With a solid growth trajectory, having expanded its operations into China and acquired a California company, Jamieson is well-positioned in the nutraceutical market, especially given the minimal impact from tariffs. The company has been able to consistently grow its dividend at a rate of 14% over the past five years, providing an appealing yield of 2.55%. Analysts suggest that despite the recent appreciation in stock price, the likelihood of a takeout is greater than market expectations, making it an attractive buy at this point. Overall, the sentiment from experts reflects confidence in the company's strategic direction and financial health.

consensus icon
Consensus
Buy
valuation icon
Valuation
Undervalued
review icon
Similar
Herbalife,HLF
HOLD

He likes the trend towards health and wellness through supplements and protein shakes. The company has been given a license to sell their branded product in China. His fund will continue to hold this stock.

PAST TOP PICK

(A Top Pick July 20/17, Up 56%) He looks for companies that dominate their market. This is the number one consumer healthcare brand. More than the next 5 largest competitors combined. It was a show-me story at the time. It needs to penetrate other geographical markets like China for continued growth. It is fairly valued at this price.

COMMENT

Smaller cap than she would buy. Vitamin manufacturer and retailer. A good one to own.

TOP PICK

It is the most prominent name in wellness and vitamins. This company is becoming globally entrenched, but it is very Canadian. It will carry on growing. It has had great numbers. They are at the low end of the price range as holistic people would be willing to pay three times more for the pills. He thinks it has growth potential. (Analysts’ target: $22.25).

TOP PICK

It is the MacDonald’s of the vitamin business. It is the number one Canadian consumer health brand. They have more market share than their 5 biggest peers combined. They have exposure in China. He thinks it will be a success-IPO story like DOL-T. It is now going to be a show-me story as they grow their top line.

Showing 31 to 35 of 35 entries